These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 16921053)
1. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J; J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053 [TBL] [Abstract][Full Text] [Related]
2. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. Kolb EA; Kushner BH; Gorlick R; Laverdiere C; Healey JH; LaQuaglia MP; Huvos AG; Qin J; Vu HT; Wexler L; Wolden S; Meyers PA J Clin Oncol; 2003 Sep; 21(18):3423-30. PubMed ID: 12972518 [TBL] [Abstract][Full Text] [Related]
3. [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS]. Fröhlich B; Ahrens S; Burdach S; Klingebiel T; Ladenstein R; Paulussen M; Zoubek A; Jürgens H Klin Padiatr; 1999; 211(4):284-90. PubMed ID: 10472563 [TBL] [Abstract][Full Text] [Related]
4. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma? Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797 [TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055 [TBL] [Abstract][Full Text] [Related]
6. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313 [TBL] [Abstract][Full Text] [Related]
7. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596 [TBL] [Abstract][Full Text] [Related]
8. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H; J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150 [TBL] [Abstract][Full Text] [Related]
9. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388 [TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience. Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621 [TBL] [Abstract][Full Text] [Related]
11. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience. Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434 [TBL] [Abstract][Full Text] [Related]
12. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma. Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419 [TBL] [Abstract][Full Text] [Related]
13. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910 [TBL] [Abstract][Full Text] [Related]
14. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200 [TBL] [Abstract][Full Text] [Related]
15. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors. Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276 [TBL] [Abstract][Full Text] [Related]
16. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Diaz MA; Vicent MG; Madero L Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802 [TBL] [Abstract][Full Text] [Related]
17. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma. Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346 [TBL] [Abstract][Full Text] [Related]
18. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. Bernstein ML; Devidas M; Lafreniere D; Souid AK; Meyers PA; Gebhardt M; Stine K; Nicholas R; Perlman EJ; Dubowy R; Wainer IW; Dickman PS; Link MP; Goorin A; Grier HE; ; ; J Clin Oncol; 2006 Jan; 24(1):152-9. PubMed ID: 16382125 [TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063 [TBL] [Abstract][Full Text] [Related]
20. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ; J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]